SCHEMBL15742170

SCHEMBL15742170

CC(C)n1c(COC2CCCCO2)nc2cnc(N)cc21

nearest known ligand 0.40

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ CDK4 P11802 1/20 0.40
▸ CCND1 P24385 1/20 0.40
▸ CCND3 P30281 1/20 0.40
▸ CDK6 Q00534 1/20 0.40
▸ KDM4C Q9H3R0 1/20 0.37
▸ NPC1 O15118 1/20 0.36
▸ RAB9A P51151 1/20 0.36
▸ EGFR P00533 8/20 0.35
▸ L3MBTL1 Q9Y468 1/20 0.35
▸ POLB P06746 1/20 0.34
▸ DHFR P00374 1/20 0.33
▸ BRD4 O60885 1/20 0.33
▸ MEN1 O00255 2/20 0.32
▸ KMT2A Q03164 2/20 0.32
▸ MET P08581 1/20 0.32
▸ ICAM1 P05362 1/20 0.31
▸ SELE P16581 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15742212 0.88 CDK4 (0.40) CDK4CCND1CCND3CDK6KDM4C
SCHEMBL15741944 0.81 EGFR (0.49) EGFR
SCHEMBL15749289 0.80 KDM4C (0.38) CDK4CCND1CCND3CDK6KDM4C
SCHEMBL15749050 0.79 CDK4 (0.39) CDK4CCND1CCND3CDK6KDM4C
SCHEMBL19015446 0.79 CDK4 (0.39) CDK4CCND1CCND3CDK6KDM4C
SCHEMBL15741987 0.79 CDK4 (0.39) CDK4CCND1CCND3CDK6KDM4C
SCHEMBL19015241 0.78 EGFR (0.60) EGFR
SCHEMBL15742169 0.75 EGFR (0.52) EGFR
SCHEMBL19861637 0.75 EGFR (0.54) EGFR
SCHEMBL19015630 0.75 EGFR (0.54) EGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2922851-A1 AMINOPYRIMIDINE COMPOUNDS AS INHIBITORS OF T790M CONTAINING EGFR MUTANTS Genentech, Inc. (US) 2015-09-30 — — EP disclosed
WO-2014081718-A1 AMINOPYRIMIDINE COMPOUNDS AS INHIBITORS OF T790M CONTAINING EGFR MUTANTS GENENTECH, INC. (US) 2014-05-30 — — WO disclosed
Send feedback